Works matching IS 0344-5704 AND VI 67 AND IP 6 AND DT 2011

Results: 33

A comparative study of pharmacokinetics, urinary excretion and tissue distribution of platinum in rats following a single-dose oral administration of two platinum(IV) complexes LA-12 (OC-6-43)-bis(acetato)(1-adamantylamine)amminedichloroplatinum( IV) and satraplatin (OC-6-43)-bis(acetato)amminedichloro(cyclohexylamine)platinum(I V)

Published in:

2011

By:

Sova P;
Mistr A;
Kroutil A;
Semerád M;
Chlubnová H;
Hrusková V;
Chládková J;
Chládek J

Publication type:

Journal Article

Plasma and CNS pharmacokinetics of O4-benzylfolic acid (O4BF) and metabolite in a non-human primate model.

Published in:

2011

By:

Chuk MK;
Cole DE;
McCully C;
Loktionova NA;
Pegg AE;
Parker RJ;
Pauly G;
Widemann BC;
Balis FM;
Fox E;
Chuk, Meredith K;
Cole, Diane E;
McCully, Cynthia;
Loktionova, Natalia A;
Pegg, Anthony E;
Parker, Robert J;
Pauly, Gary;
Widemann, Brigitte C;
Balis, Frank M;
Fox, Elizabeth

Publication type:

journal article

A Phase 1 study of UCN-01 in combination with irinotecan in patients with resistant solid tumor malignancies.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 6, p. 1225, doi. 10.1007/s00280-010-1410-1

By:

Fracasso, Paula;
Williams, Kerry;
Chen, Ronald;
Picus, Joel;
Ma, Cynthia;
Ellis, Matthew;
Tan, Benjamin;
Pluard, Timothy;
Adkins, Douglas;
Naughton, Michael;
Rader, Janet;
Arquette, Matthew;
Fleshman, James;
Creekmore, Allison;
Goodner, Sherry;
Wright, Lisa;
Guo, Zhanfang;
Ryan, Christine;
Tao, Yu;
Soares, Eliane

Publication type:

Article

A multicenter phase I trial of metronomic oral vinorelbine plus cisplatin in patients with NSCLC.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 6, p. 1239, doi. 10.1007/s00280-010-1415-9

By:

Pallis, Athanasios;
Chandrinos, Vassilis;
Pavlakou, Georgia;
Xenidis, Nikolaos;
Varthalitis, Ioannis;
Vardakis, Nikolaos;
Vamvakas, Lambros;
Kontopodis, Emmanouel;
Rovithi, Maria;
Georgoulias, Vassilis

Publication type:

Article

A comparative study of pharmacokinetics, urinary excretion and tissue distribution of platinum in rats following a single-dose oral administration of two platinum(IV) complexes LA-12 ( OC-6-43)-bis(acetato)(1-adamantylamine)amminedichloroplatinum(IV) and satraplatin ( OC-6-43)-bis(acetato)amminedichloro(cyclohexylamine)platinum(IV)

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 6, p. 1247, doi. 10.1007/s00280-010-1411-0

By:

Sova, Petr;
Mistr, Adolf;
Kroutil, Ales;
Semerád, Martin;
Chlubnová, Hana;
Hrusková, Veronika;
Chládková, Jirina;
Chládek, Jaroslav

Publication type:

Article

Phase II study of docetaxel, capecitabine, and cisplatin as neoadjuvant chemotherapy for locally advanced breast cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 6, p. 1257, doi. 10.1007/s00280-010-1401-2

By:

Lu, Yen-Shen;
Chen, Dar-Ren;
Tseng, Ling-Min;
Yeh, Dah-Cherng;
Chen, Shou-Tung;
Hsieh, Chia-Ming;
Wang, Hwei-Chung;
Yeh, Hsien-Tang;
Kuo, Sung-Hsin;
Huang, Chiun-Sheng

Publication type:

Article

A phase II study of paclitaxel by weekly 1-h infusion for advanced or recurrent esophageal cancer in patients who had previously received platinum-based chemotherapy.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 6, p. 1265, doi. 10.1007/s00280-010-1422-x

By:

Kato, Ken;
Tahara, Makoto;
Hironaka, Shuichi;
Muro, Kei;
Takiuchi, Hiroya;
Hamamoto, Yasuo;
Imamoto, Haruhiko;
Amano, Norihito;
Seriu, Taku

Publication type:

Article

Pharmacokinetic and pharmacodynamic properties of an oral formulation of the histone deacetylase inhibitor Belinostat (PXD101).

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 6, p. 1273, doi. 10.1007/s00280-010-1419-5

By:

Steele, N.;
Plumb, J.;
Vidal, L.;
Tjørnelund, J.;
Knoblauch, P.;
Buhl-Jensen, P.;
Molife, R.;
Brown, R.;
de Bono, J.;
Evans, T.

Publication type:

Article

A phase II and pharmacokinetic study of first line S-1 for advanced gastric cancer in Taiwan.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 6, p. 1281, doi. 10.1007/s00280-010-1416-8

By:

Chen, Jen-Shi;
Chao, Yee;
Hsieh, Ruey-Kuen;
Cheng, Ann-Lii;
Chen, Po-Min;
Chiou, Tzeon-Jye;
Chao, Tsu-Yi;
Yeh, Kun-Huei;
Chen, Li-Tzong;
Whang-Peng, Jacqueline

Publication type:

Article

Plasma and CNS pharmacokinetics of O-benzylfolic acid (OBF) and metabolite in a non-human primate model.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 6, p. 1291, doi. 10.1007/s00280-010-1407-9

By:

Chuk, Meredith;
Cole, Diane;
McCully, Cynthia;
Loktionova, Natalia;
Pegg, Anthony;
Parker, Robert;
Pauly, Gary;
Widemann, Brigitte;
Balis, Frank;
Fox, Elizabeth

Publication type:

Article

Satraplatin (JM-216) mediates G2/M cell cycle arrest and potentiates apoptosis via multiple death pathways in colorectal cancer cells thus overcoming platinum chemo-resistance.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 6, p. 1299, doi. 10.1007/s00280-010-1428-4

By:

Kalimutho, Murugan;
Minutolo, Antonella;
Grelli, Sandro;
Formosa, Amanda;
Sancesario, Giulia;
Valentini, Alessandra;
Federici, Giorgio;
Bernardini, Sergio

Publication type:

Article

Double-blind crossover study to assess potential differences in cytochrome P450 3A4 activity in healthy subjects receiving ondansetron plus dexamethasone, with and without aprepitant.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 6, p. 1313, doi. 10.1007/s00280-010-1421-y

By:

Stoch, S.;
Gargano, Cynthia;
Valentine, Jack;
Braun, Matthew;
Murphy, M.;
Fedgchin, Margaret;
Majumdar, Anup;
Pequignot, Edward;
Gottesdiener, Keith;
Petty, Kevin;
Panebianco, Deborah;
Dean, Dennis;
Kraft, Walter;
Greenberg, Howard

Publication type:

Article

Phase II study of biweekly S-1 and oxaliplatin combination chemotherapy in metastatic colorectal cancer and pharmacogenetic analysis.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 6, p. 1323, doi. 10.1007/s00280-010-1425-7

By:

Hong, Junshik;
Han, Sae-Won;
Ham, Hye;
Kim, Tae-Yong;
Choi, In;
Kim, Byung-Su;
Oh, Do-Youn;
Im, Seock-Ah;
Kang, Gyeong;
Bang, Yung-Jue;
Kim, Tae-You

Publication type:

Article

Detection of doxorubicin hydrochloride accumulation in the rat brain after morphine treatment by mass spectrometry.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 6, p. 1333, doi. 10.1007/s00280-010-1429-3

By:

Sardi, Iacopo;
Marca, Giancarlo;
Giovannini, Maria;
Malvagia, Sabrina;
Guerrini, Renzo;
Genitori, Lorenzo;
Massimino, Maura;
Aricò, Maurizio

Publication type:

Article

Preclinical pharmacokinetic, toxicological and biomarker evaluation of SR16157, a novel dual-acting steroid sulfatase inhibitor and selective estrogen receptor modulator.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 6, p. 1341, doi. 10.1007/s00280-010-1430-x

By:

Rausch, Linda;
Green, Carol;
Steinmetz, Karen;
LeValley, Sue;
Catz, Paul;
Zaveri, Nurulain;
Schweikart, Karen;
Tomaszewski, Joseph;
Mirsalis, Jon

Publication type:

Article

NCT01110291: induction of CYP3A activity and lowered exposure to docetaxel in patients with primary breast cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 6, p. 1353, doi. 10.1007/s00280-010-1426-6

By:

Hilli, Johanna;
Sailas, Liisa;
Jyrkkiö, Sirkku;
Pyrhönen, Seppo;
Laine, Kari

Publication type:

Article

p53-dependent anticancer effects of leptomycin B on lung adenocarcinoma.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 6, p. 1369, doi. 10.1007/s00280-010-1434-6

By:

Shao, Changxia;
Lu, Chuanwen;
Chen, Lixia;
Koty, Patrick;
Cobos, Everardo;
Gao, Weimin

Publication type:

Article

Phase II study of biweekly docetaxel and S-1 combination chemotherapy as first-line treatment for advanced gastric cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 6, p. 1363, doi. 10.1007/s00280-010-1433-7

By:

Kunisaki, Chikara;
Takahashi, Masazumi;
Makino, Hirochika;
Oshima, Takashi;
Fujii, Shoichi;
Takagawa, Ryo;
Kimura, Jun;
Kosaka, Takashi;
Ono, Hidetaka;
Akiyama, Hirotoshi;
Kameda, Kunio;
Kito, Fumihiko;
Morita, Satoshi;
Endo, Itaru

Publication type:

Article

Uncoupling protein downregulation in doxorubicin-induced heart failure improves mitochondrial coupling but increases reactive oxygen species generation.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 6, p. 1381, doi. 10.1007/s00280-010-1441-7

By:

Bugger, Heiko;
Guzman, Cinthia;
Zechner, Christoph;
Palmeri, Monica;
Russell, Kerry;
Russell, Raymond

Publication type:

Article

Picoplatin overcomes resistance to cell toxicity in small-cell lung cancer cells previously treated with cisplatin and carboplatin.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 6, p. 1389, doi. 10.1007/s00280-010-1435-5

By:

Tang, Chi-Hui;
Parham, Christi;
Shocron, Ellyn;
McMahon, Gerald;
Patel, Neela

Publication type:

Article

Cell cycle and apoptosis regulatory protein (CARP)-1 is a novel, adriamycin-inducible, diffuse large B-cell lymphoma (DLBL) growth suppressor.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 6, p. 1401, doi. 10.1007/s00280-010-1442-6

By:

Levi, Edi;
Zhang, Liyue;
Aboukameel, Amro;
Rishi, Sunny;
Mohammad, Ramzi;
Polin, Lisa;
Hatfield, James;
Rishi, Arun

Publication type:

Article

Corticorelin acetate, a synthetic corticotropin-releasing factor with preclinical antitumor activity, alone and with bevacizumab, against human solid tumor models.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 6, p. 1415, doi. 10.1007/s00280-010-1437-3

By:

Gamez, Idoia;
Ryan, Robert;
Reid, Lakesha;
Routt, Sheri;
Hollister, Beth

Publication type:

Article

Feasibility study of adjuvant chemotherapy with S-1 plus cisplatin for gastric cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 6, p. 1423, doi. 10.1007/s00280-010-1432-8

By:

Takahari, D.;
Hamaguchi, T.;
Yoshimura, K.;
Katai, H.;
Ito, S.;
Fuse, N.;
Kinoshita, T.;
Yasui, H.;
Terashima, M.;
Goto, M.;
Tanigawa, N.;
Shirao, K.;
Sano, T.;
Sasako, M.

Publication type:

Article

A multi-institution phase II study of gemcitabine/S-1 combination chemotherapy for patients with advanced biliary tract cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 6, p. 1429, doi. 10.1007/s00280-010-1443-5

By:

Kanai, Masashi;
Yoshimura, Kenichi;
Tsumura, Takehiko;
Asada, Masanori;
Suzuki, Chihiro;
Niimi, Miyuki;
Matsumoto, Shigemi;
Nishimura, Takafumi;
Nitta, Takashi;
Yasuchika, Kentaro;
Taura, Kojiro;
Mori, Yukiko;
Hamada, Akihiko;
Inoue, Naoya;
Tada, Shinsuke;
Yanagihara, Kazuhiro;
Yazumi, Shujiro;
Osaki, Yukio;
Chiba, Tsutomu;
Ikai, Iwao

Publication type:

Article

Phase I/II study of a combination of docetaxel, capecitabine, and cisplatin (DXP) as first-line chemotherapy in patients with advanced gastric cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 6, p. 1435, doi. 10.1007/s00280-010-1444-4

By:

Kang, Yoon-Koo;
Ryu, Min-Hee;
Yoo, Changhoon;
Chang, Heung-Moon;
Yook, Jeong;
Oh, Sung;
Kim, Byung;
Kim, Tae

Publication type:

Article

Interleukin-1 receptor antagonist attenuates cyclophosphamide-induced mucositis in a murine model.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 6, p. 1445, doi. 10.1007/s00280-010-1439-1

By:

Xiang, Di;
Guo, Yiping;
Zhang, Jing;
Gao, Jin;
Lu, Huili;
Zhu, Shunying;
Wu, Mingyuan;
Yu, Yan;
Han, Wei

Publication type:

Article

Erlotinib efficacy and cerebrospinal fluid concentration in patients with lung adenocarcinoma developing leptomeningeal metastases during gefitinib therapy.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 6, p. 1465, doi. 10.1007/s00280-011-1555-6

By:

Masuda, Takeshi;
Hattori, Noboru;
Hamada, Akinobu;
Iwamoto, Hiroshi;
Ohshimo, Shinichiro;
Kanehara, Masashi;
Ishikawa, Nobuhisa;
Fujitaka, Kazunori;
Haruta, Yoshinori;
Murai, Hiroshi;
Kohno, Nobuoki

Publication type:

Article

Phase II trial of cisplatin plus prednisone in docetaxel-refractory castration-resistant prostate cancer patients.

Published in:

2011

By:

Buonerba, Carlo;
Federico, Piera;
D'Aniello, Carmine;
Rescigno, Pasquale;
Cavaliere, Carla;
Puglia, Livio;
Ferro, Matteo;
Altieri, Vincenzo;
Perdonà, Sisto;
De Placido, Sabino;
Lorenzo, Giuseppe

Publication type:

Report

Prospectives and limitations by a novel algorithm.

Published in:

2011

By:

Holweger, Karin;
Lipp, Hans-Peter

Publication type:

Letter

Estimating the correct way of calculating the carboplatin dose.

Published in:

2011

By:

Sierra-Sánchez, Jesús;
González-Carrascosa, Triana

Publication type:

Letter

Erratum to: Phase II trial of cisplatin plus prednisone in docetaxel-refractory castration-resistant prostate cancer patients.

Published in:

2011

By:

Buonerba, Carlo;
Federico, Piera;
D'Aniello, Carmine;
Rescigno, Pasquale;
Cavaliere, Carla;
Puglia, Livio;
Ferro, Matteo;
Altieri, Vincenzo;
Perdonà, Sisto;
Placido, Sabino;
Di Lorenzo, Giuseppe

Publication type:

Correction Notice

The effects of CYP3A4, CYP3A5, ABCB1, ABCC2, ABCG2 and SLCO1B3 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of docetaxel in nasopharyngeal carcinoma patients.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 6, p. 1471, doi. 10.1007/s00280-011-1625-9

By:

Chew, Sin-Chi;
Singh, Onkar;
Chen, Xiangai;
Ramasamy, Rathi;
Kulkarni, Tejal;
Lee, Edmund;
Tan, Eng-Huat;
Lim, Wan-Teck;
Chowbay, Balram

Publication type:

Article

Nitric oxide: role in tumour biology and iNOS/NO-based anticancer therapies.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 6, p. 1211, doi. 10.1007/s00280-011-1654-4

By:

Singh, Simendra;
Gupta, Alok

Publication type:

Article